-
Survivor Profile
Handle With CareBrain cancer survivor Lanette Veres sends cards and packages to others with the disease. She believes no one should face cancer alone.
by Lindsey Konkel
-
Forward Look
Targeted Treatments for TotsNew law mandates that cancer drugs get tested in kids in clinical trials.
by Sharon Tregaskis
-
Cancer Patient Advocates Find Strength in Numbers
Patient advocates have become a vital part of the San Antonio Breast Cancer Symposium. Opportunities for advocates continue to multiply.
by Marci A. Landsmann
-
Cancer and Credit
The financial burden of a cancer diagnosis can lower a patient's credit score.
by Shelly Rosenfeld
-
First Ladies of Africa Issue Call to Address Cancer Crisis
A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
-
From the Editor-in-Chief
Value-Based Cancer Care: Paying for PerformanceThe Centers for Medicare & Medicaid Services implements incentive programs to reward quality care.
by William G. Nelson, MD, PhD
-
Forward Look
A New Use for Patient DataGregory Daniel on real-world evidence for cancer drug approvals.
by Sue Rochman
-
Policy Matters
FDA Seeks to Improve Access to Investigational Oncology DrugsProject Facilitate offers assistance to medical professionals who want investigational drugs for their cancer patients.
by Richard Pazdur, MD
-
Survivor Profile
A Sister’s CircleSchool counselor Diane Nathaniel creates communities for herself and those around her in Brooklyn and beyond. Her cancer diagnosis led her into patient advocacy.
by Marci A. Landsmann
-
Get Involved
Stay CloseParticipants in Airbnb's Open Homes program help nonprofit organizations to provide temporary lodging for cancer patients.
by Katherine Malmo
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff